ZEKE CAPITAL ADVISORS, LLC - INHIBIKASE THERAPEUTICS INC ownership

INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 25 filers reported holding INHIBIKASE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ZEKE CAPITAL ADVISORS, LLC ownership history of INHIBIKASE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$46,900
-44.8%
93,8000.0%0.00%
-50.0%
Q3 2022$85,000
+21.4%
93,8000.0%0.01%
+20.0%
Q2 2022$70,000
-49.6%
93,8000.0%0.01%
-28.6%
Q1 2022$139,000
+0.7%
93,8000.0%0.01%
-12.5%
Q4 2021$138,000
-22.5%
93,8000.0%0.01%
-20.0%
Q3 2021$178,000
-32.3%
93,8000.0%0.01%
-41.2%
Q2 2021$263,000
+132.7%
93,800
+398.9%
0.02%
+112.5%
Q1 2021$113,000
-13.1%
18,8000.0%0.01%
-27.3%
Q4 2020$130,00018,8000.01%
Other shareholders
INHIBIKASE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 1,076,500$1,593,0001.68%
Lynwood Capital Management Inc. 120,000$178,0000.19%
Retirement Planning Co of New England, Inc. 116,402$172,0000.10%
Kepos Capital LP 700,000$1,036,0000.08%
HAMILTON LANE ADVISORS LLC 165,635$245,0000.06%
Redmond Asset Management, LLC 122,682$182,0000.05%
SABBY MANAGEMENT, LLC 99,000$147,0000.02%
Antara Capital LP 303,000$448,0000.01%
ZEKE CAPITAL ADVISORS, LLC 93,800$139,0000.01%
Shay Capital LLC 20,000$30,0000.00%
View complete list of INHIBIKASE THERAPEUTICS INC shareholders